Paper

Xanthone suppresses allergic contact dermatitis in vitro and in vivo.

Published Dec 7, 2019 · Aye Aye, Young-Jae Song, Yong-Deok Jeon

International immunopharmacology

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro StudyRigorous Journal

Study Snapshot

Xanthone shows potential in treating allergic inflammatory diseases by reducing pro-inflammatory cytokines and chemokines, and inhibiting anaphylactic shock and cutaneous anaphylaxis.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Xanthone suppresses allergic contact dermatitis in vitro and in vivo.

References

Citations